MedPath

Efficacy of Boswellia carteri B. on mixed urinary incontinence in wome

Early Phase 1
Conditions
mixed urinary incontinence.
Mixed incontinence
N39.46
Registration Number
IRCT20190310042998N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Women 55 to 80 years old
patients with mixed urinary incontinence

Exclusion Criteria

patients with Neurogenic bladder
patients with Pelvic organ prolapse with stage>=2
patients with urinary and vaginal infections
Drug use for this disorder and mental disorders and hormonal medications in the last month
Contraindication of anticholinergic use by the patient
Drug addiction
History of pelvic radiotherapy and chemotherapy
History of urogenital Cancer
Having psychological disorders such as Alzheimer's
Severe digestive problems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of urinary leakage. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF questionnaire.;Urinary incontinence leakage rate. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF questionnaire.;Urine leakage time. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of Life. Timepoint: At the beginning of the study, week 2, week 4 and week 6. Method of measurement: ICIQ-SF and I-QOL questionnaires.
© Copyright 2025. All Rights Reserved by MedPath